China Traditional Chinese Medicine Holdings Co Ltd (HK:0570)
:0570
Want to see HK:0570 full AI Analyst Report?
0570 Stock Chart & Stats
HK$2.16
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$2.16
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$1.59 - HK$2.68
Previous CloseN/A
Volume9.47M
Average Volume (3M)51.13M
Market Cap
HK$8.11B
Enterprise ValueHK$5.58B
Total Cash (Recent Filing)HK$5.16B
Total Debt (Recent Filing)HK$2.49B
Price to Earnings (P/E)―
Beta0.34
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.66%
Share Statistics
EPS (TTM)-0.07
Shares Outstanding5,035,802,000
10 Day Avg. Volume46,853,920
30 Day Avg. Volume51,130,115
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)0.46
Price to Sales (P/S)0.64
P/FCF Ratio4.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.1
Revenue Forecast (FY)HK$14.45B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetImproved leverage and low debt into 2024–2025 reduce refinancing and liquidity risk, giving management flexibility to fund capex, R&D or M&A without urgent external financing. This durable strength supports resilience through industry cycles and preserves strategic optionality.
Strong Recent Cash GenerationConsistent positive operating and free cash flow in the last two years shows the business can convert sales into cash even amid earnings weakness. Durable cash generation underpins working capital needs, dividend funding and selective reinvestment, aiding financial stability over months to quarters.
High Dividend Yield Backed By Cash FlowA materially high yield, combined with recent positive free cash flow and a conservative balance sheet, suggests the payout may be supported structurally rather than purely by leverage. For income-focused holders, this represents a lasting cash-return feature if cash generation remains predictable.
Bears Say
Earnings Deterioration To LossA structural slide from multi-year profitability to a 2025 net loss weakens return on equity and limits internal funding for growth. Persistent losses impair compounding, reduce strategic reinvestment capacity, and heighten dependence on operational fixes to restore durable shareholder value creation.
Inconsistent And Declining RevenueRepeated revenue declines and volatility indicate unstable demand or pricing, making margin recovery and capacity planning difficult. Structural top-line inconsistency undermines scale economics and forecasting, limiting management's ability to commit to long-term investments or restore past profitability levels.
Volatile Longer-term Cash FlowHistoric swings in free cash flow reduce predictability for dividends, debt paydown and reinvestment. Even with recent positive FCF, prior negative years and a sharp 2025 decline signal exposure to working-capital shifts or one-off items that could reappear, stressing long-term capital allocation.
China Traditional Chinese Medicine Holdings Co News
0570 FAQ
What was China Traditional Chinese Medicine Holdings Co Ltd’s price range in the past 12 months?
China Traditional Chinese Medicine Holdings Co Ltd lowest stock price was HK$1.59 and its highest was HK$2.68 in the past 12 months.
What is China Traditional Chinese Medicine Holdings Co Ltd’s market cap?
China Traditional Chinese Medicine Holdings Co Ltd’s market cap is HK$8.11B.
When is China Traditional Chinese Medicine Holdings Co Ltd’s upcoming earnings report date?
China Traditional Chinese Medicine Holdings Co Ltd’s upcoming earnings report date is Aug 27, 2026 which is in 99 days.
How were China Traditional Chinese Medicine Holdings Co Ltd’s earnings last quarter?
China Traditional Chinese Medicine Holdings Co Ltd released its earnings results on Mar 20, 2026. The company reported -HK$0.051 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.051.
Is China Traditional Chinese Medicine Holdings Co Ltd overvalued?
According to Wall Street analysts China Traditional Chinese Medicine Holdings Co Ltd’s price is currently Overvalued.
Does China Traditional Chinese Medicine Holdings Co Ltd pay dividends?
China Traditional Chinese Medicine Holdings Co Ltd pays a Notavailable dividend of HK$0.086 which represents an annual dividend yield of 3.66%. See more information on China Traditional Chinese Medicine Holdings Co Ltd dividends here
What is China Traditional Chinese Medicine Holdings Co Ltd’s EPS estimate?
China Traditional Chinese Medicine Holdings Co Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Traditional Chinese Medicine Holdings Co Ltd have?
China Traditional Chinese Medicine Holdings Co Ltd has 5,035,802,000 shares outstanding.
What happened to China Traditional Chinese Medicine Holdings Co Ltd’s price movement after its last earnings report?
China Traditional Chinese Medicine Holdings Co Ltd reported an EPS of -HK$0.051 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.529%.
Which hedge fund is a major shareholder of China Traditional Chinese Medicine Holdings Co Ltd?
Currently, no hedge funds are holding shares in HK:0570
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
China Traditional Chinese Medicine Holdings Co Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-44.28%
12-Months-Change
Fundamentals
Return on Equity
-1.64%
Trailing 12-Months
Asset Growth
-3.64%
Trailing 12-Months
Company Description
China Traditional Chinese Medicine Holdings Co Ltd
China Traditional Chinese Medicine Holdings Co. Limited, an investment holding company, engages in the research and development, production, and sale of Chinese medicine and pharmaceutical products in the People's Republic of China. The company offers granules, finished drugs, decoction pieces, and healthcare products. It is also involved in the plantation and management of Chinese medicinal herbs; manufacturing of traditional Chinese medicines (TCM); trading of pharmaceutical products; provision of TCM marketing, advertising, and consulting services; and retail of pharmaceuticals and decoction products. The company also provides property leasing services. It sells its products to hospitals and retail pharmacies. The company was formerly known as China Traditional Chinese Medicine Co. Limited and changed its name to China Traditional Chinese Medicine Holdings Co. Limited in July 2016. China Traditional China Traditional Chinese Medicine Holdings Co. Limited was founded in 1573 and is headquartered in Wan Chai, Hong Kong.
Technical Analysis
Guangzhou Baiyunshan Pharmaceutical Holdings Company
―
Wai Yuen Tong Medicine Holdings Limited
―
Grand Pharmaceutical Group Limited
―
Golden Throat Holdings Group Co Ltd
―
Shandong Xinhua Pharmaceutical Company Limited Class H
―
Options Prices
Currently, No data available
---